Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Johansson

Showing results (131-140 of 228) with videos related to

Pageof 23
Sort By:
Radiology|August 25, 2007
Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosisCharlotte Ebeling Barbier, Tomas Bjerner, Tomas Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2020
The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic FatLars Lind, Samira Salihovic, Ulf Risérus, et al.
World Journal of Hepatology|July 21, 2020
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian populationLars Lind, Lars Johansson, Håkan Ahlström, et al.
Diabetes, Obesity & Metabolism|February 20, 2020
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetesLars Johansson, Paul D Hockings, Eva Johnsson, et al.
Diabetes, Obesity & Metabolism|September 13, 2021
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudyJuan P Frías, Jill Maaske, Lisa Suchower, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 SequencesIrina Velikyan, Martin Bossart, Torsten Haack, et al.
Thrombosis and Haemostasis|February 19, 2002
Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarctionPer Ladenvall, Lars Johansson, Jan-Håkan Jansson, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 16, 2010
Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent settingKim Ekblom, Stefan L Marklund, Lars Johansson, et al.
Cerebrovascular Diseases Extra|April 24, 2017
Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort StudyKristina Johansson, Jan-Håkan Jansson, Lars Johansson, et al.
Journal of the American College of Cardiology|September 17, 2011
Prevalence of unrecognized myocardial infarction detected with magnetic resonance imaging and its relationship to cerebral ischemic lesions in both sexesCharlotte Ebeling Barbier, Ruta Nylander, Raquel Themudo, et al.
Pageof 23

Showing results (131-140 of 228) with videos related to

Sort By:
Pageof 23
Radiology|August 25, 2007
Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosisCharlotte Ebeling Barbier, Tomas Bjerner, Tomas Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2020
The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic FatLars Lind, Samira Salihovic, Ulf Risérus, et al.
World Journal of Hepatology|July 21, 2020
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian populationLars Lind, Lars Johansson, Håkan Ahlström, et al.
Diabetes, Obesity & Metabolism|February 20, 2020
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetesLars Johansson, Paul D Hockings, Eva Johnsson, et al.
Diabetes, Obesity & Metabolism|September 13, 2021
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudyJuan P Frías, Jill Maaske, Lisa Suchower, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 SequencesIrina Velikyan, Martin Bossart, Torsten Haack, et al.
Thrombosis and Haemostasis|February 19, 2002
Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarctionPer Ladenvall, Lars Johansson, Jan-Håkan Jansson, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 16, 2010
Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent settingKim Ekblom, Stefan L Marklund, Lars Johansson, et al.
Cerebrovascular Diseases Extra|April 24, 2017
Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort StudyKristina Johansson, Jan-Håkan Jansson, Lars Johansson, et al.
Journal of the American College of Cardiology|September 17, 2011
Prevalence of unrecognized myocardial infarction detected with magnetic resonance imaging and its relationship to cerebral ischemic lesions in both sexesCharlotte Ebeling Barbier, Ruta Nylander, Raquel Themudo, et al.
Pageof 23